Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
Public ClinicalTrials.gov record NCT01701219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study of safety and efficacy of ceftaroline fosamil in Subjects with Staphylococcus aureus Bacteremia or with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia persisting after at least 72 hours of vancomycin and/or daptomycin treatment.
Study identification
- NCT ID
- NCT01701219
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2013 (Type not available)
- Primary completion
- May 2014 (Actual)
- Completion
- Jul 2014 (Actual)
- Last update posted
- Jul 31, 2014
2013 – 2014
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Birmingham | Alabama | 35294 | — |
| Investigational Site | Sacramento | California | 95817 | — |
| Investigational Site | San Francisco | California | 94110 | — |
| Investigational Site | Sylmar | California | 91342 | — |
| Investigational Site | Torrance | California | 90502 | — |
| Investigational Site | Hartford | Connecticut | 06102 | — |
| Investigational Site | Pensacola | Florida | 32504 | — |
| Investigational Site | Stuart | Florida | 34994 | — |
| Investigational Site | Decatur | Georgia | 30030 | — |
| Investigational Site | Macon | Georgia | 31201 | — |
| Investigational Site | Chicago | Illinois | 60612 | — |
| Investigational Site | Fort Wayne | Indiana | 46845 | — |
| Investigational Site | Louisville | Kentucky | 40202 | — |
| Investigational Site | Boston | Massachusetts | 02111 | — |
| Investigational Site | Detroit | Michigan | 48201 | — |
| Investigational Site | Detroit | Michigan | 48202 | — |
| Investigational Site | Grosse Pointe Woods | Michigan | 48236 | — |
| Investigational Site | Royal Oak | Michigan | 48073 | — |
| Investigational Site | Laconia | New Hampshire | 03246 | — |
| Investigational Site | Neptune City | New Jersey | 07753 | — |
| Investigational Site | Newark | New Jersey | 07102 | — |
| Investigational Site | Jamaica | New York | 11418 | — |
| Investigational Site | Toledo | Ohio | 43620 | — |
| Investigational Site | Greenville | South Carolina | 29605 | — |
| Investigational Site | Houston | Texas | 77030 | — |
| Investigational Site | Annandale | Virginia | 22003 | — |
| Investigational Site | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01701219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2014 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01701219 live on ClinicalTrials.gov.